The overall goal of the Glioblastoma (GBM) Therapeutics Network (GTN) U19 grant awarded to City of Hope, is to develop superior treatments for patients with GBM, the most common and aggressive primary
City of Hope physicians are experts in using leading-edge treatments to diagnose and treat amyloidosis. Located in So. California.
By combining science and compassion, City of Hope has transformed health care since our inception. Learn how we’re saving lives now and in the future.